Earlier this month, Duke University Executive Vice President for Health Affairs and School of Medicine Dean Mary Klotman, MD, announced the launch of Discovery AI, a new strategic research initiative designed to accelerate the application of artificial intelligence and machine learning to discovery science in biomedicine. Discovery AI is focused on deeply integrating computational and biological expertise with the goal of extending the frontiers of biological discovery across multiple scales. Scott H. Soderling, PhD, chair of the Department of Cell Biology, interim chair of the Department of Biochemistry, and David Page, PhD, chair of the Department of Biostatistics and Bioinformatics, will lead an effort that combines excellence in biology, engineering, and data science in a seamless and collaborative framework, bringing quantitative and experimental approaches into closer alignment. Duke AI Health Faculty Council member Ricardo Henao, PhD, is among numerous faculty experts who will be contributing to the initiative.
